Literature DB >> 21459274

The effect of comorbidity on the competing risk of sudden and nonsudden death in an ambulatory heart failure population.

Brian Clarke1, Jonathan Howlett, John Sapp, Pantelis Andreou, Ratika Parkash.   

Abstract

BACKGROUND: Sudden death (SD) and non-sudden cardiac death are responsible for the majority of deaths in patients with heart failure. We sought to identify the influence of comorbid illness (Charlson Comorbidity Index [CCI]) on competing modes of death in heart failure.
METHODS: A retrospective analysis of 824 patients followed in a tertiary care heart failure clinic was performed. We analyzed the cumulative incidence of sudden and nonsudden death. Competing risk regression was used to examine the association between medical comorbidities and mode of death. The outcomes of interest were overall mortality, SD, SD and/or appropriate implantable cardioverter-defibrillator therapy (ICD), and non-SD.
RESULTS: Mean age of the study population was 64.1 ± 14.7 years, 68.6% were male, and mean ejection fraction was 32.8% ± 13.5%. Over a mean follow-up of 4.4 years, 229 patients (27.8%) died. SD accounted for 33 deaths (14.4%), whereas SD/appropriate ICD therapy occurred in 56 patients (24.5%). The risk of non-SD and total mortality increased (P < .0001) as the CCI increased, whereas the risk of SD decreased (P = .03). The cumulative incidence of SD, SD and/or ventricular tachycardia/fibrillation, and non-SD at 5 years was 5.6%, 9.1%, and 27.8%, respectively. In multivariate competing risk analysis, advancing age, New York Heart Association class, and a CCI >4 were significantly associated with non-SD.
CONCLUSION: Patients with heart failure with significant comorbidities are much more likely to sustain non-SD. These findings may have implications in optimal selection of patients with heart failure for interventions such as prophylactic ICD therapy.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21459274     DOI: 10.1016/j.cjca.2010.12.053

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  12 in total

1.  Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator Therapies.

Authors:  Alexandra M Hajduk; Jerry H Gurwitz; Grace Tabada; Frederick A Masoudi; David J Magid; Robert T Greenlee; Sue Hee Sung; Andrea E Cassidy-Bushrow; Taylor I Liu; Kristi Reynolds; David H Smith; Frances Fiocchi; Robert Goldberg; Thomas M Gill; Nigel Gupta; Pamela N Peterson; Claudio Schuger; Humberto Vidaillet; Stephen C Hammill; Heather Allore; Alan S Go
Journal:  J Am Geriatr Soc       Date:  2019-03-20       Impact factor: 5.562

2.  Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).

Authors:  Yiyi Zhang; Robert Kennedy; Elena Blasco-Colmenares; Barbara Butcher; Sanaz Norgard; Zayd Eldadah; Timm Dickfeld; Kenneth A Ellenbogen; Joseph E Marine; Eliseo Guallar; Gordon F Tomaselli; Alan Cheng
Journal:  Heart Rhythm       Date:  2014-05-02       Impact factor: 6.343

Review 3.  The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient.

Authors:  Robert Lee Page; Joann Lindenfeld
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

4.  Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.

Authors:  James A Fallavollita; Jonathan D Dare; Randolph L Carter; Sunil Baldwa; John M Canty
Journal:  Circ Cardiovasc Imaging       Date:  2017-08       Impact factor: 7.792

5.  Comorbidity assessment as predictor of short and long-term mortality in elderly patients with hemodynamically stable acute pulmonary embolism.

Authors:  Hernan Polo Friz; Valeria Corno; Annalisa Orenti; Chiara Buzzini; Chiara Crivellari; Francesco Petri; Melisa Polo Friz; Veronica Punzi; Daniela Teruzzi; Luca Cavalieri d'Oro; Cristina Giannattasio; Giuseppe Vighi; Claudio Cimminiello; Patrizia Boracchi
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

Review 6.  Magnitude and Impact of Multimorbidity on Clinical Outcomes in Older Adults with Cardiovascular Disease: A Literature Review.

Authors:  Mayra Tisminetzky; Robert Goldberg; Jerry H Gurwitz
Journal:  Clin Geriatr Med       Date:  2016-05       Impact factor: 3.076

7.  Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice.

Authors:  Frederick A Masoudi; Alan S Go; David J Magid; Andrea E Cassidy-Bushrow; Jonathan M Doris; Frances Fiocchi; Romel Garcia-Montilla; Karen A Glenn; Robert J Goldberg; Nigel Gupta; Jerry H Gurwitz; Stephen C Hammill; John J Hayes; Nathaniel Jackson; Alan Kadish; Michael Lauer; Aaron W Miller; Deborah Multerer; Pamela N Peterson; Liza M Reifler; Kristi Reynolds; Jane S Saczynski; Claudio Schuger; Param P Sharma; David H Smith; Mary Suits; Sue Hee Sung; Paul D Varosy; Humberto J Vidaillet; Robert T Greenlee
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11

Review 8.  How To Better Identify Patients That Do Not Benefit From Prophylactic ICD Therpy.

Authors:  Ian Mann; Amit Kaura; Paul A Scott
Journal:  J Atr Fibrillation       Date:  2014-10-31

9.  Prevalence of comorbidities and their impact on hospital management and short-term outcomes in Vietnamese patients hospitalized with a first acute myocardial infarction.

Authors:  Hoa L Nguyen; Quang Ngoc Nguyen; Duc Anh Ha; Dat Tuan Phan; Nguyen Hanh Nguyen; Robert J Goldberg
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

10.  Right atrial to left atrial area ratio on early echocardiography predicts long-term survival after acute pulmonary embolism.

Authors:  Vincent Chow; Austin Chin Chwan Ng; Tommy Chung; Liza Thomas; Leonard Kritharides
Journal:  Cardiovasc Ultrasound       Date:  2013-05-31       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.